Literature DB >> 20842550

Venous leg ulcerations: a treatment update.

Ronda S Farah1, Mark D P Davis.   

Abstract

OPINION STATEMENT: Selecting the appropriate treatment for venous leg ulcerations is essential for optimal wound healing and patient quality of life. Compression therapy remains the mainstay of treatment for these wounds. Compression methods should be carefully selected and tailored for compatibility with patients' daily life. Pain management should not be neglected. When response to compression therapy is limited, adjuvant therapy such as medication, débridement, or surgical procedures should be considered on an individual basis.

Entities:  

Year:  2010        PMID: 20842550     DOI: 10.1007/s11936-010-0066-9

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  20 in total

Review 1.  Recent advances and emerging treatments.

Authors:  Stuart Enoch; Joseph E Grey; Keith G Harding
Journal:  BMJ       Date:  2006-04-22

2.  State-of-the-art treatment of chronic leg ulcers: A randomized controlled trial comparing vacuum-assisted closure (V.A.C.) with modern wound dressings.

Authors:  Jeroen D D Vuerstaek; Tryfon Vainas; Jan Wuite; Patty Nelemans; Martino H A Neumann; Joep C J M Veraart
Journal:  J Vasc Surg       Date:  2006-09-26       Impact factor: 4.268

Review 3.  Percutaneous management of chronic deep venous reflux: review of experimental work and early clinical experience with bioprosthetic valve.

Authors:  Dusan Pavcnik; Barry Uchida; John Kaufman; Monica Hinds; Frederick S Keller; Josef Rösch
Journal:  Vasc Med       Date:  2008-02       Impact factor: 3.239

4.  Vacuum-assisted closure: a new method for wound control and treatment: clinical experience.

Authors:  L C Argenta; M J Morykwas
Journal:  Ann Plast Surg       Date:  1997-06       Impact factor: 1.539

Review 5.  Severe chronic venous insufficiency: primary treatment with sclerofoam.

Authors:  John J Bergan; Luigi Pascarella
Journal:  Semin Vasc Surg       Date:  2005-03       Impact factor: 1.000

6.  Recombinant human granulocyte-macrophage colony-stimulating factor applied locally in low doses enhances healing and prevents recurrence of chronic venous ulcers.

Authors:  E Jaschke; A Zabernigg; C Gattringer
Journal:  Int J Dermatol       Date:  1999-05       Impact factor: 2.736

7.  Randomized, double-blind, placebo-controlled, dose- ranging study of granulocyte-macrophage colony stimulating factor in patients with chronic venous leg ulcers.

Authors:  R M Da Costa; F M Ribeiro Jesus; C Aniceto; M Mendes
Journal:  Wound Repair Regen       Date:  1999 Jan-Feb       Impact factor: 3.617

8.  A bilayered living skin construct (APLIGRAF) accelerates complete closure of hard-to-heal venous ulcers.

Authors:  V Falanga; M Sabolinski
Journal:  Wound Repair Regen       Date:  1999 Jul-Aug       Impact factor: 3.617

9.  Phase I study of H5.020CMV.PDGF-beta to treat venous leg ulcer disease.

Authors:  David J Margolis; Lee M Morris; Maryte Papadopoulos; Linda Weinberg; Jennifer C Filip; Stephanie A Lang; Sachin S Vaikunth; Timothy M Crombleholme
Journal:  Mol Ther       Date:  2009-07-28       Impact factor: 11.454

10.  Clinical and economic impact of Apligraf for the treatment of nonhealing venous leg ulcers.

Authors:  David Fivenson; Lubomira Scherschun
Journal:  Int J Dermatol       Date:  2003-12       Impact factor: 2.736

View more
  1 in total

Review 1.  Skin grafting for venous leg ulcers.

Authors:  June E Jones; E Andrea Nelson; Aws Al-Hity
Journal:  Cochrane Database Syst Rev       Date:  2013-01-31
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.